Share >  
Share
Share on Tumblr

Topline

News »

   latest by relevance
Talwalkar fit to maintain 30-35% growth ahead: Gawande
May 23, 2012 at 10:58 | Source: CNBC-TV18
Anant Gawande, CFO, Talwalkars Better Value Fitness told CNBC-TV18 that finacial year 2013 has started on a positive note for the company. Its topline grew 30% and bottonline 48% last year and it is confident of maintaining the company's grwoth rate at 30-35%.
IIFL sees 20-25% growth in finance distribution arm ahead
May 15, 2012 at 17:34 | Source: CNBC-TV18
IIFL reported a healthy top-line growth in FY11 and posted a consolidated net profit of Rs 47 crore against Rs 36 crore (QoQ). In an interview with CNBC-TV18, Nirmal Jain, Chairman, IIFL said that given the multiple headwinds for their business, the equity brokerage business has posted a decent growth of 16% in the fourth quarter of FY12.
Dishman Pharma expects 25% growth in FY13
May 15, 2012 at 16:33 | Source: CNBC-TV18
Dishman Pharmaceuticals posted a 13.24% topline growth in the fourth quarter of FY12 and reported a consolidated net profit of Rs 312.94 million for the quarter ended 31 March, 2012, up 37.30% from Rs 227.92 million in the corresponding quarter last year.
Orchid Chemicals eyes 15-20% growth in FY13
May 14, 2012 at 17:21 | Source: CNBC-TV18
After not so impressive results and a fall in Q4 net profit by 75%, K Raghavendra Rao, CMD, Orchid Chemicals said that the companys topline and bottomline performance has been affected mainly due to the repayment of Foreign Currency Convertible Bonds (FCCB).
L&T beats estimates, Kotak Sec justifies result
May 14, 2012 at 15:01 | Source: CNBC-TV18
Engineering and construction major Larsen and Toubro (L&T) beat all estimates to report a net profit of Rs 1,920 crore, up 31.6% (YoY). In an interview with CNBC-TV18, Sanjeev Zarbade of Kotak Securities analysed the Q4 results of L&T and said that the topline is almost in line with their expectations.
Indian Bank falls 8% on lower than estimates nos in Q4
May 11, 2012 at 15:20 | Source: Moneycontrol.com
Shares of public sector lender Indian Bank tanked more than 8% after reporting quite lower than expected topline and bottomline numbers due to rising non-performing assets (NPAs) and higher provisions.

Videos »
Talwalkar fit to maintain 30-35% growth ahead: Gawande
IIFL sees 20-25% growth in finance distribution arm ahead
Dishman Pharma expects 25% growth in FY13
Orchid Chemicals eyes 15-20% growth in FY13
L&T beats estimates, Kotak Sec justifies result
more »

Photos »

  /  
News across the web »
ICICI Pru Life to use multiple CEOs to drive profitability
ICICI Prudential Life Insurance has created a new formula to drive profitability and growth in the organisation, an integrated geographic structure. This change from a vertical structure to a geograph...
May 27, 2012 at 00:56 | Source: Business Standard
Amul goes for a bigger bite of chocolate bars
Kolkata, May 24: Amul India plans to rejig its chocolate portfolio. On the cards is focus on larger bars of over 100 grams to shore up topline and ramping up of chocolate production capacity at Anand...
May 25, 2012 at 16:22 | Source: The Hindu BusinessLine
Crompton Greaves net profit seen down 34% to Rs 166cr, margins eyed
NEW DELHI: Crompton Greaves is expected to report a 34 percent drop in its fourth quarter net profit numbers to Rs 166 crore against Rs 251 crore in the year-ago period, according to ET Now estimates....
May 25, 2012 at 16:22 | Source: Economic Times
‘Limit exposure to equity at 20-30%'
Retail investors should limit their exposure to equities, cautioned Mr Nirmal Jain, Founder and Chairman, India Infoline Ltd. In an interview to Business Line, Mr Jain spoke about the issues affectin...
May 25, 2012 at 12:51 | Source: The Hindu BusinessLine
Tanishq lowers growth forecast to 30% for FY13Still better than industry as most players posting negative growth: Tanishq VP (Retail and Marketing)
Tata Group's jewellery arm Tanishq today said it has scaled down its growth forecast for the current fiscal due to slowdown but would continue with its expansion plans. The growth rate we believe will...
May 25, 2012 at 06:42 | Source: Business Standard
more »
Interact & exchange stock tips & market info »

Cool_Head

Platinum Member

317 Followers

Suzlon Energy  

Topline better must be beocz of forex movements......bottom-lin...

8.33 PM May 26th

skhvr

Platinum Member

28 Followers

Reliance Infra  

Just evaluate result , what is positive ??? Next year fcb to redreem t...

3.27 PM May 26th

Web Messenger

Platinum Member

107836 Followers

News Now  

Source:The Hindu BusinessLine - Kolkata, May 24: Amul India plans to ...

11.37 AM May 26th

Related News »
Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer
Celldex Therapeutics, Inc. (NASDAQ: CLDX - News) today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD ...
May 25, 2012 at 12:14 | Source: Yahoo Finance
Topline 300-Mile Tesla Model S Projected to Earn 265-Mile EPA Range
The top-of-the-line Tesla Model S with a claimed 300-mile range is expected to earn an EPA window sticker displaying an official range of 265 miles. The Model S’ drawn-out unveiling has ingrained three specific driving ranges related to battery size ...
May 15, 2012 at 08:01 | Source: MotorTrend Magazine
Maximillian Schell to topline Marx biopic
Maximilian Schell will topline a Karl Marx biopic about his last days in Algeria. Cinema Libre Studio and the Algerian Ministry of Culture announced Thursday in Cannes that they have finalized a co-production deal to produce the feature film. The deal ...
May 17, 2012 at 13:07 | Source: Variety
Carrie Fisher, Dr. Reef Karim topline Psych Week on Discovery starting June 3
Tune in alert for Discovery Fit & Health’s Psych Week beginning Sunday, June 3. Hosted by actress, noted recovering addict and former electric shock therapy patient Carrie Fisher, Discovery Fit & Health opens a meaningful dialogue on mental health with ...
May 23, 2012 at 16:42 | Source: Monsters and Critics
DBV Technologies: First Quarter 2012 Topline, Scientific Activity and Upcoming Clinical Data
DBV Technologies (Paris:DBV) (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today its first quarter topline and its intense scientific activity and clinical data disclosure ...
May 15, 2012 at 08:30 | Source: TMCnet
RInfra sees 3-fold rise in infra revenue this fiscal
Mumbai, May 27 (PTI) Anil Ambani-promoted Reliance Infrastructure (RInfra) has said it is expecting almost three-fold rise in revenue from the infra vertical to Rs 1,000 crore this fiscal, which had contributed only 1.5 percent to its topline last fiscal.
May 27, 2012 at 07:11 | Source: in.com
Topline impresses new sponsor
AN impressive performance by the Topline Warriors reserve grade in their first ever formal match saw them win the hearts of their new sponsor. The club which was formed a few months ago took part in the Vodafone Cup Suva zone competition at Buckhurst Park ...
May 19, 2012 at 21:33 | Source: Fiji Times
Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC)
NEW YORK, May 15, 2012 (BUSINESS WIRE) -- Pfizer Inc announced today that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(R) (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after ...
May 15, 2012 at 22:42 | Source: Marketwatch
Pfizer Provides Topline Results From Phase 3 Study Of Torisel As Second-Line Treatment
The FINANCIAL -- Pfizer Inc announced that the Phase 3 INTORSECT study, evaluating TORISEL in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT therapy, did not meet the primary endpoint of prolonging ...
May 18, 2012 at 08:41 | Source: The FINANCIAL
First quarter 2012 topline, scientific activity and upcoming clinical data
Bagneux, France, May 15, 2012 - DBV Technologies (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today its first quarter topline and its intense scientific activity and clinical data ...
May 14, 2012 at 23:55 | Source: Phramalive.com

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window